Coronavirus channel feed

Trump and Navar­ro press again for hy­drox­y­chloro­quine. Can the FDA stay in­de­pen­dent?

5 years ago

OWS shifts spot­light to drugs to fight Covid-19, hand­ing Re­gen­eron $450M to be­gin large scale man­u­fac­tur­ing in the US

5 years ago
R&D

Covid-19 roundup: Squab­bles with gov­ern­ment de­lay Mod­er­na’s PhI­II — re­ports; No­vavax se­cures largest Warp Speed deal yet: $1.6B

5 years ago

Covid-19 roundup: Teamed up with NIH, Re­gen­eron launch­es PhI­II pre­ven­tion tri­al for an­ti­body cock­tail

5 years ago

Which drug de­vel­op­ers of­fer Trump a quick, game-chang­ing ‘so­lu­tion’ as the pan­dem­ic roars back? Eli Lil­ly and Ab­Cellera look to break out of the pack

5 years ago
Bioregnum
Pharma

Tes­la chief Elon Musk teams up with Covid-19 play­er Cure­Vac to build 'R­NA mi­cro­fac­to­ries'

5 years ago
People

Pfiz­er shares surge on pos­i­tive im­pact of their mR­NA Covid-19 vac­cine — part­nered with BioN­Tech — in an ear­ly-stage study

5 years ago
R&D

Covid-19 has roiled clin­i­cal tri­al plans around the world, rais­ing con­cerns over the in­dus­try’s fu­ture on new drug ap­provals

5 years ago
R&D

Covid-19 roundup: Vac­cines will need to beat place­bo by 50% to qual­i­fy for FDA OK; UK tri­al drops Kale­tra

5 years ago

WHO ACT-Ac­cel­er­a­tor pri­or­i­tizes glob­al vac­cine ap­proach

5 years ago

Covid-19 roundup: Temasek leads a $250M raise for BioN­Tech as first Covid-19 mR­NA vac­cine da­ta looms; Chi­na's mil­i­tary OKs first use of coro­n­avirus vac­cine

5 years ago

Covid-19 roundup: Mod­er­na en­lists Catal­ent as man­u­fac­tur­ing part­ner, se­cur­ing fill-fin­ish ca­pac­i­ty for the first 100M dos­es

5 years ago

Covid-19 roundup: An­tho­ny Fau­ci, Stephen Hahn tes­ti­fy in Con­gress; Chi­na's Sinopharm speeds in­to PhI­II vac­cine tri­al

5 years ago

Hahn tes­ti­fies on Covid-19 re­sponse, says FDA on tar­get to hit user fee goals

5 years ago
FDA+

Law­mak­ers ask FDA to out­line Covid-19 vac­cine ap­proval process

5 years ago
FDA+

Covid-19 roundup: $71M from DoD to In­ovio; Pigs pro­vide clues on Ox­ford vac­cine; Google lends su­per­com­put­ing to an­tivi­ral hunt

5 years ago

Covid-19 roundup: In fifth open let­ter, Daniel O’Day touts in­halant remde­sivir, promis­es 2M dos­es by year's end; Mer­ck’s an­tivi­ral moves in­to PhII

5 years ago

Covid-19 roundup: One Chi­nese biotech en­ters clin­ic, an­oth­er eyes fall com­ple­tion, a third shoots for 2021 — while the Warp Speed gen­er­al re­mains Sino-skep­tic

5 years ago

FDA of­fers sta­tis­ti­cal guid­ance for tri­als im­pact­ed by Covid-19

5 years ago
FDA+

Covid-19 roundup: Roche's Actem­ra marred by neg­a­tive re­sults; Here comes an­oth­er sin­gle-armed remde­sivir tri­al

5 years ago

Chi­nese vac­cine de­vel­op­ers have be­gun to shed some se­cre­cy around Covid-19 can­di­dates. What do we know?

5 years ago
China
In Focus

UK in­ves­ti­ga­tors say a drug re­duced Covid-19 deaths for the first time. The world pon­ders what to do next

5 years ago
FDA+

Covid-19 roundup: No­vavax re­cruits As­traZeneca vet as its new CMO — right af­ter David Mott jumps on the board; Op­er­a­tion Warp Speed will cut to 7 can­di­dates

5 years ago

Covid-19 roundup: An old, cheap steroid proves to be a ma­jor boon to coro­n­avirus pa­tients; BAR­DA puts $85M be­hind Re­gen­eron an­ti­body ef­fort

5 years ago
First page Previous page 48495051525354 Next page Last page
A service from the Financial Times